血液科指南

订阅

MedSci主页 / 所有栏目 / 血液科指南

2021 BSHI指南：造血祖细胞移植HLA配型和供体选择

2021-02-10 Int J Immunogenet . 2021 Feb 10.

造血祖细胞移植

2021年2月，英国组织相容性和免疫遗传学学会(BSHI)更新发布了造血祖细胞移植HLA配型和供体选择指南。文章介绍了异基因供体的选择，针对造血祖细胞移植HLA配型和供体选择提供指导建议。

中文标题：

2021 BSHI指南：造血祖细胞移植HLA配型和供体选择

英文标题：

BSHI guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation

发布机构：

发布日期：

2021-02-10

简要介绍：

2021年2月，英国组织相容性和免疫遗传学学会(BSHI)更新发布了造血祖细胞移植HLA配型和供体选择指南。文章介绍了异基因供体的选择，针对造血祖细胞移植HLA配型和供体选择提供指导建议。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 BSHI指南：造血祖细胞移植HLA配型和供体选择.pdf)] GetToolGuiderByIdResponse(projectId=1, id=f95661c00206e766, title=2021 BSHI指南：造血祖细胞移植HLA配型和供体选择, enTitle=BSHI guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation, guiderFrom=Int J Immunogenet . 2021 Feb 10., authorId=0, author=, summary=2021年2月，英国组织相容性和免疫遗传学学会(BSHI)更新发布了造血祖细胞移植HLA配型和供体选择指南。文章介绍了异基因供体的选择，针对造血祖细胞移植HLA配型和供体选择提供指导建议。, cover=https://img.medsci.cn/202138/1615138760268_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Wed Feb 10 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年2月，英国组织相容性和免疫遗传学学会(BSHI)更新发布了造血祖细胞移植HLA配型和供体选择指南。文章介绍了异基因供体的选择，针对造血祖细胞移植HLA配型和供体选择提供指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=110631, tagName=造血祖细胞移植)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=11773, guiderKeyword=HLA匹配, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4050, appHits=72, showAppHits=0, pcHits=539, showPcHits=3978, likes=2, shares=3, comments=12, approvalStatus=1, publishedTime=Mon Mar 08 01:49:10 CST 2021, publishedTimeString=2021-02-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Mon Mar 08 01:39:26 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 23:15:00 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 BSHI指南：造血祖细胞移植HLA配型和供体选择.pdf)])
2021 BSHI指南：造血祖细胞移植HLA配型和供体选择.pdf
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1066884, encodeId=9d7e1066884e7, content=多看多了解，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211028/1e6bd3cfdbea45cd9111f9548626d470/a99e858b87e346c2b51ffc96965c28ba.jpg, createdBy=3b7b5651639, createdName=香草🌿, createdTime=Thu Nov 04 11:37:29 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949311, encodeId=ed2a949311ed, content=造血祖细胞移植, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Thu Mar 18 17:58:57 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949306, encodeId=806794930623, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Thu Mar 18 17:47:34 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949305, encodeId=fbf0949305d4, content=不错 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Thu Mar 18 17:47:30 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949304, encodeId=b84994930482, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Thu Mar 18 17:47:00 CST 2021, time=2021-03-18, status=1, ipAttribution=)]
    2021-11-04 香草🌿

    多看多了解，谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1066884, encodeId=9d7e1066884e7, content=多看多了解，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211028/1e6bd3cfdbea45cd9111f9548626d470/a99e858b87e346c2b51ffc96965c28ba.jpg, createdBy=3b7b5651639, createdName=香草🌿, createdTime=Thu Nov 04 11:37:29 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949311, encodeId=ed2a949311ed, content=造血祖细胞移植, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Thu Mar 18 17:58:57 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949306, encodeId=806794930623, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Thu Mar 18 17:47:34 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949305, encodeId=fbf0949305d4, content=不错 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Thu Mar 18 17:47:30 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949304, encodeId=b84994930482, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Thu Mar 18 17:47:00 CST 2021, time=2021-03-18, status=1, ipAttribution=)]
    2021-03-18 ms2000001748592435

    造血祖细胞移植

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1066884, encodeId=9d7e1066884e7, content=多看多了解，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211028/1e6bd3cfdbea45cd9111f9548626d470/a99e858b87e346c2b51ffc96965c28ba.jpg, createdBy=3b7b5651639, createdName=香草🌿, createdTime=Thu Nov 04 11:37:29 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949311, encodeId=ed2a949311ed, content=造血祖细胞移植, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Thu Mar 18 17:58:57 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949306, encodeId=806794930623, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Thu Mar 18 17:47:34 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949305, encodeId=fbf0949305d4, content=不错 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Thu Mar 18 17:47:30 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949304, encodeId=b84994930482, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Thu Mar 18 17:47:00 CST 2021, time=2021-03-18, status=1, ipAttribution=)]
    2021-03-18 ms2000001748592435

    很好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1066884, encodeId=9d7e1066884e7, content=多看多了解，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211028/1e6bd3cfdbea45cd9111f9548626d470/a99e858b87e346c2b51ffc96965c28ba.jpg, createdBy=3b7b5651639, createdName=香草🌿, createdTime=Thu Nov 04 11:37:29 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949311, encodeId=ed2a949311ed, content=造血祖细胞移植, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Thu Mar 18 17:58:57 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949306, encodeId=806794930623, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Thu Mar 18 17:47:34 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949305, encodeId=fbf0949305d4, content=不错 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Thu Mar 18 17:47:30 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949304, encodeId=b84994930482, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Thu Mar 18 17:47:00 CST 2021, time=2021-03-18, status=1, ipAttribution=)]
    2021-03-18 ms2000001748592435

    不错

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1066884, encodeId=9d7e1066884e7, content=多看多了解，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211028/1e6bd3cfdbea45cd9111f9548626d470/a99e858b87e346c2b51ffc96965c28ba.jpg, createdBy=3b7b5651639, createdName=香草🌿, createdTime=Thu Nov 04 11:37:29 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949311, encodeId=ed2a949311ed, content=造血祖细胞移植, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Thu Mar 18 17:58:57 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949306, encodeId=806794930623, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Thu Mar 18 17:47:34 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949305, encodeId=fbf0949305d4, content=不错 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Thu Mar 18 17:47:30 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949304, encodeId=b84994930482, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03295451837, createdName=ms2000001748592435, createdTime=Thu Mar 18 17:47:00 CST 2021, time=2021-03-18, status=1, ipAttribution=)]
    2021-03-18 ms2000001748592435

    学习了

    0